Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 13, 2015 - Issue 11
Submit an article Journal homepage
280
Views
5
CrossRef citations to date
0
Altmetric
Drug profile

Asunaprevir (BMS-650032) for the treatment of hepatitis C virus

Nobuhisa AkamatsuArtificial Organ and Transplantation Surgery Division, Department of Surgery, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
,
Yasuhiko SugawaraDivisions of Hepato-Biliary-Pancreatic Surgery and Liver transplantation, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8935, JapanCorrespondence[email protected]
&
Norihiro KokudoArtificial Organ and Transplantation Surgery Division, Department of Surgery, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
Pages 1307-1317 | Published online: 28 Sep 2015

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Isabella Esposito, Sebastián Marciano & Julieta Trinks. (2018) Pharmacokinetic and pharmacodynamic evaluation of daclatasvir, asunaprevir plus beclabuvir as a fixed-dose co-formulation for the treatment of hepatitis C. Expert Opinion on Drug Metabolism & Toxicology 14:6, pages 649-657.
Read now

Articles from other publishers (4)

Chunying Luo, Maxwell Ampomah-Wireko, Huanhuan Wang, Chunli Wu, Qing Wang, Hui Zhang & Yaquan Cao. (2021) Isoquinolines: Important Cores in Many Marketed and Clinical Drugs. Anti-Cancer Agents in Medicinal Chemistry 21:7, pages 811-824.
Crossref
Nicholas A. Meanwell, Ramkumar Rajamani, Paul M. Scola & Li-Qiang Sun. 2019. HCV: The Journey from Discovery to a Cure. HCV: The Journey from Discovery to a Cure 317 354 .
Haruki Uojima, Shuzo Kobayashi, Hisashi Hidaka, Shuichi Matsumoto, Takayasu Ohtake, Takeshi Kinbara, Machiko Oka, Yasuhiro Yamanouchi, Takehiko Kunieda, Hiroki Yamanoue, Takayuki Kanemaru, Kazuhiko Tsutsumi, Tomoaki Fujikawa, Ji Hyun Sung & Makoto Kako. (2017) Virological response to daclatasvir and asunaprevir combination therapy for chronic hepatitis C virus genotype 1b infection in dialysis patients: a prospective, multicenter study. Renal Replacement Therapy 3:1.
Crossref
Kiyohiko Omichi, Nobuhisa Akamatsu, Kazuhiro Mori, Junichi Togashi, Junichi Arita, Junichi Kaneko, Kiyoshi Hasegawa, Yoshihiro Sakamoto & Norihiro Kokudo. (2017) Asunaprevir/daclatasvir and sofosbuvir/ledipasvir for recurrent hepatitis C following living donor liver transplantation. Hepatology Research 47:11, pages 1093-1101.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.